Literature DB >> 17160616

Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations.

B Klarner1, H H Klünemann, R Lürding, C Aslanidis, R Rupprecht.   

Abstract

Niemann-Pick type C disease is a fatal neurovisceral disorder linked to dysregulation in cholesterol processing. A medication for this disease is currently being tested in clinical trials. However, there is a lack of information on neuropsychological testing parameters for this disease. One aim of this pilot study was to evaluate a test battery that could be used to assess cognitive deficits in different stages of the disease. A second aim was to determine whether specific functional deficits are associated with certain disease stages. Eight men and two women (19-40 years of age) harbouring mutations in the gene coding for the cholesterol trafficking protein NPC1 were put through the same test battery independently of their disease stage. The external staging criterion was based on a five-step clinical scale. Trail Making tests A & B and verbal fluency were sensitive indicators at early stages of NPC. Corsi Block-Tapping, Mini Mental Status, Find Similarities and Clock Drawing showed abnormal results in patients with advanced disease. The Grooved Pegboard, Trail Making and Mosaic tests were unsuitable in advanced disease due to impaired fine motor skills. We observed that visuospatial working memory was less affected by the neurodegenerative process than verbal working memory. The series of tests used here could be supplemented by the severe impairment battery and Raven matrices tests for patients with advanced disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160616     DOI: 10.1007/s10545-006-0417-6

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

Review 1.  Therapy of Niemann-Pick disease, type C.

Authors:  Marc C Patterson; Frances Platt
Journal:  Biochim Biophys Acta       Date:  2004-10-11

2.  AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease.

Authors:  Marco A Passini; Shannon L Macauley; Michael R Huff; Tatyana V Taksir; Jie Bu; I-Huan Wu; Peter A Piepenhagen; James C Dodge; Lamya S Shihabuddin; Catherine R O'Riordan; Edward H Schuchman; Gregory R Stewart
Journal:  Mol Ther       Date:  2005-05       Impact factor: 11.454

3.  Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.

Authors:  James C Dodge; Jennifer Clarke; Antonius Song; Jie Bu; Wendy Yang; Tatyana V Taksir; Denise Griffiths; Michael A Zhao; Edward H Schuchman; Seng H Cheng; Catherine R O'Riordan; Lamya S Shihabuddin; Marco A Passini; Gregory R Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

4.  Cholesterol accumulation sequesters Rab9 and disrupts late endosome function in NPC1-deficient cells.

Authors:  Ian G Ganley; Suzanne R Pfeffer
Journal:  J Biol Chem       Date:  2006-04-26       Impact factor: 5.157

5.  AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease.

Authors:  Christine M Barbon; Robin J Ziegler; Chester Li; Donna Armentano; Maribeth Cherry; Robert J Desnick; Edward H Schuchman; Seng H Cheng
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

6.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis.

Authors:  E D Carstea; J A Morris; K G Coleman; S K Loftus; D Zhang; C Cummings; J Gu; M A Rosenfeld; W J Pavan; D B Krizman; J Nagle; M H Polymeropoulos; S L Sturley; Y A Ioannou; M E Higgins; M Comly; A Cooney; A Brown; C R Kaneski; E J Blanchette-Mackie; N K Dwyer; E B Neufeld; T Y Chang; L Liscum; J F Strauss; K Ohno; M Zeigler; R Carmi; J Sokol; D Markie; R R O'Neill; O P van Diggelen; M Elleder; M C Patterson; R O Brady; M T Vanier; P G Pentchev; D A Tagle
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

7.  Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype.

Authors:  G Millat; C Marçais; M A Rafi; T Yamamoto; J A Morris; P G Pentchev; K Ohno; D A Wenger; M T Vanier
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

8.  Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C.

Authors:  Eric C Bascuñan-Castillo; Robert P Erickson; Christy M Howison; Robert J Hunter; Randall H Heidenreich; Chad Hicks; Theodore P Trouard; Robert J Gillies
Journal:  J Appl Genet       Date:  2004       Impact factor: 3.240

9.  Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests.

Authors:  R M Ruff; S B Parker
Journal:  Percept Mot Skills       Date:  1993-06

10.  Genetic and demographic aspects of Nova Scotia Niemann-Pick disease (type D).

Authors:  E J Winsor; J P Welch
Journal:  Am J Hum Genet       Date:  1978-09       Impact factor: 11.025

View more
  24 in total

1.  Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C.

Authors:  Nicole M Yanjanin; Jorge I Vélez; Andrea Gropman; Kelly King; Simona E Bianconi; Sandra K Conley; Carmen C Brewer; Beth Solomon; William J Pavan; Mauricio Arcos-Burgos; Marc C Patterson; Forbes D Porter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

2.  Long-Term Neuropsychological Outcomes from an Open-Label Phase I/IIa Trial of 2-Hydroxypropyl-β-Cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1.

Authors:  Cristan A Farmer; Audrey Thurm; Nicole Farhat; Simona Bianconi; Lee Ann Keener; Forbes D Porter
Journal:  CNS Drugs       Date:  2019-07       Impact factor: 5.749

3.  Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study.

Authors:  M Walterfang; B Patenaude; L A Abel; H Kluenemann; E A Bowman; M C Fahey; P Desmond; W Kelso; D Velakoulis
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-13       Impact factor: 3.825

4.  Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.

Authors:  Stefano Tozza; Raffaele Dubbioso; Rosa Iodice; Antonietta Topa; Marcello Esposito; Lucia Ruggiero; Emanuele Spina; Anna De Rosa; Francesco Saccà; Lucio Santoro; Fiore Manganelli
Journal:  Neurol Sci       Date:  2018-03-13       Impact factor: 3.307

Review 5.  Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management.

Authors:  Thomas Rego; Sarah Farrand; Anita M Y Goh; Dhamidhu Eratne; Wendy Kelso; Simone Mangelsdorf; Dennis Velakoulis; Mark Walterfang
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 6.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

7.  Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease?

Authors:  Fiore Manganelli; Raffaele Dubbioso; Rosa Iodice; Antonietta Topa; Andrea Dardis; Cinzia Valeria Russo; Lucia Ruggiero; Stefano Tozza; Alessandro Filla; Lucio Santoro
Journal:  J Neurol       Date:  2014-02-26       Impact factor: 4.849

8.  Cohort study of neurocognitive functioning and adaptive behaviour in children and adolescents with Niemann-Pick Disease type C1.

Authors:  Audrey Thurm; Cristan Farmer; Nicole Yanjanin Farhat; Edythe Wiggs; David Black; Forbes D Porter
Journal:  Dev Med Child Neurol       Date:  2015-11-19       Impact factor: 5.449

9.  Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators.

Authors:  Miriam Stampfer; Susanne Theiss; Yasmina Amraoui; Xuntian Jiang; Sigrid Keller; Daniel S Ory; Eugen Mengel; Christine Fischer; Heiko Runz
Journal:  Orphanet J Rare Dis       Date:  2013-02-22       Impact factor: 4.123

10.  Disease and patient characteristics in NP-C patients: findings from an international disease registry.

Authors:  Marc C Patterson; Eugen Mengel; Frits A Wijburg; Audrey Muller; Barbara Schwierin; Harir Drevon; Marie T Vanier; Mercé Pineda
Journal:  Orphanet J Rare Dis       Date:  2013-01-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.